Drug Release Studies of Naproxen Agglomerates Produced by the Antisolvent Approach in the Presence of Hydroxypropyl Cellulose Drug release studies of naproxen agglomerates
Iranian Journal of Pharmaceutical Sciences,
Vol. 7 No. 4 (2011),
1 October 2011
,
Page 221-229
https://doi.org/10.22037/ijps.v7.41293
Abstract
In this study, the effect of recrystallization of naproxen in the presence of hydroxypropyl cellulose (HPC) on the release rate of drug was investigated. Crystals were generated by the anti-solvent approach using the HPC solution in water as the anti-solvent. The samples were subjected to various physicochemical evaluations such as crystal size, scanning electron microscopy, Fourier transform infrared (FTIR) spectroscopy, solubility, wettability and dissolution studies. Results revealed that HPC play a key role in controlling the primary crystal size,
morphology, size and surface properties of naproxen agglomerates. Crystallization of naproxen in the presence of HPC caused a marked modification of its dissolution. The particles
obtained in the presence of HPC exhibited slower dissolution rate compared to those produced in the absence of HPC. This was attributed to the adsorption of HPC on the surface of the
naproxen crystals.It was shown that the solubility of naproxen increased in solution containing HPC.Moreover, there was a significant difference between the solubility of untreated naproxen and that of samples crystallized in the presence of HPC in water. Contact angle measurements revealed that control crystals obtained in the absence of HPC have a greater contact angle than those produced in the presence of HPC. FT-IR spectroscopy results indicated the absence of any interaction between drug and HPC. This study highlights the influence of polymeric additive on the crystallization process leading to modified performance.
- Additive
- Crystallization
- Dissolution
- HPC
- Naproxen
How to Cite
References
[2] Davey JR. The role of additives in precipitation processes. In: Janic, S.J., De Jong, E.S. (Eds.), Industrial Crystallization. North Holland, The Netherlands, 1982; pp. 123-35.
[3] Mullin JW. Crystallization, third ed. Butterworths, Oxford. 1993.
[4] Khamskii EV. Some problems of crystal habit modification. In: Mullin, J.W. (Ed.), Industrial Crystallization. Plenum, New York. 1976; pp. 215-21.
[5] Kibbe AH, Wade A, Weller PJ (Eds.), Handbook of Pharmaceutical Excipients, second ed., American Pharmaceutical Association, 1988; pp.223-8.
[6] Maghsoodi M, Hassan-Zadeh D, Barzegar-Jalali M, Martin G, Nokhodchi A. Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization
technique. Drug Dev Ind Pharm 2007; 33: 1216-24.
[7] Kawashima Y, Takenchi H, Niwa T, hino T, Yamakoshi M, Kihara K. Preparation of spherically agglomerated crystals of an antibacterial drug for direct tabletting by a novel spherical crystallization technique. Proc. 5 Int Conf Pharm Technol 1989; 3: 228-34. th
[8] Lu GW, Hawley M, Smith M, Geiger BM, Pfund W. Characterization of a novel polymorphic form of celecoxib. J Pharm Sci 2006; 95: 305-17.
[9] Raghavan SL, Trividic A, Davis A F, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 2001; 212: 213-21.
[10] Daniels R, Barta A. Pharmacopoeial cellulose ethers as oil-in water emulsifiers. I. interfacial properties. Eur J Pharm Biopharm 1994; 40: 128-33.
[11] Raghavan SL, Schuessel K, Davis A, Hadgraft J. Formation and stabilization of triclosan colloidal suspensions using supersaturated systems. Int J Pharm 2003; 261: 153-8.
[12] Rasenack N, Steckel H, Müller BW. Preparation of microcrystals by in situ micronization. Powder Technol 2004; 143: 291-6.
[13] Li XS, Wang JX, Shen ZG, Zhang PY, Chen JF, vYun J. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. Int J Pharm 2007; 342: 26-32.
[14] Mura P, Bettinetti GP, Cirri M, Maestrelli F, Sorrenti M, Catenacci L. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-β-cyclodextrin ternary system. Eur J Pharm Biopharm 2005; 59: 99-106.
[15] Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002; 231: 131-44.
[16] Corrigan OI. Mechanisms of dissolution of fast release solid dispersions. Drug Dev Ind Pharm 1985; 11: 697-724.
[17] Chiou W L, Chen SJ, Athanikar N. Enhancement of dissolution rates of poorly water soluble drugs by crystallization in aqueous surfactant solution. 1. sulfathiazole, prednisolone and hloramphenicol.
J Pharm Sci 1976; 65: 1702-4.
- Abstract Viewed: 283 times
- IJPS_Volume 7_Issue 4_Pages 221-229.pdf Downloaded: 199 times